Scholar Rock Holding Shares Outstanding 2017-2021 | SRRK

Scholar Rock Holding shares outstanding from 2017 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Scholar Rock Holding Annual Shares Outstanding
(Millions of Shares)
2020 31
2019 28
2018 16
2017 2
2016 2
Scholar Rock Holding Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 37
2021-03-31 36
2020-12-31 31
2020-09-30 30
2020-06-30 30
2020-03-31 30
2019-12-31 28
2019-09-30 29
2019-06-30 26
2019-03-31 26
2018-12-31 16
2018-09-30 24
2018-06-30 11
2018-03-31 3
2017-12-31
2017-09-30 2
2017-06-30 2
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.124B $0.015B
Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29